Photodynamic therapy for metastatic breast cancer
<p>Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/k...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
2014-01-01
|
Series: | Biomedical Photonics |
Subjects: | |
Online Access: | http://www.pdt-journal.com:80/jour/article/view/33 |
_version_ | 1819072484170792960 |
---|---|
author | E. V. Horanskaya M. A. Kaplan V. N. Kapinous E. V. Yaroslavtseva I. S. Spichenkova A. M. Shubina O. V. Borgul Ju. A. Ragulin M. V. Taibova |
author_facet | E. V. Horanskaya M. A. Kaplan V. N. Kapinous E. V. Yaroslavtseva I. S. Spichenkova A. M. Shubina O. V. Borgul Ju. A. Ragulin M. V. Taibova |
author_sort | E. V. Horanskaya |
collection | DOAJ |
description | <p>Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/kg body weight 3 h before treatment session (wave length 661±1 nm, плотность мощности 0,11–0,56 J/cm<span><sup>2</sup></span>), мощность на выходе волокна 0,3–2,0 Wt, light dose 50–600 J/cm<span><sup>2</sup></span>. Complete regression of metastasis was obtained in 33.6% of cases, partial – in 39.4%, stabilization – in 22.6%, progression of disease was in 4.3% of cases. The results show the perspectiveness of photodynamic therapy for metastasis as one of the step of treatment.</p><p> </p> |
first_indexed | 2024-12-21T17:38:27Z |
format | Article |
id | doaj.art-7451ba5c02244bb4b2e73034d95b127f |
institution | Directory Open Access Journal |
issn | 2413-9432 |
language | Russian |
last_indexed | 2024-12-21T17:38:27Z |
publishDate | 2014-01-01 |
publisher | Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" |
record_format | Article |
series | Biomedical Photonics |
spelling | doaj.art-7451ba5c02244bb4b2e73034d95b127f2022-12-21T18:55:42ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322014-01-0132151733Photodynamic therapy for metastatic breast cancerE. V. Horanskaya0M. A. Kaplan1V. N. Kapinous2E. V. Yaroslavtseva3I. S. Spichenkova4A. M. Shubina5O. V. Borgul6Ju. A. Ragulin7M. V. Taibova8Национальный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, Россия<p>Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/kg body weight 3 h before treatment session (wave length 661±1 nm, плотность мощности 0,11–0,56 J/cm<span><sup>2</sup></span>), мощность на выходе волокна 0,3–2,0 Wt, light dose 50–600 J/cm<span><sup>2</sup></span>. Complete regression of metastasis was obtained in 33.6% of cases, partial – in 39.4%, stabilization – in 22.6%, progression of disease was in 4.3% of cases. The results show the perspectiveness of photodynamic therapy for metastasis as one of the step of treatment.</p><p> </p>http://www.pdt-journal.com:80/jour/article/view/33рак молочной железыфотолонфотодинамическая терапиявнутрикожные метастазы |
spellingShingle | E. V. Horanskaya M. A. Kaplan V. N. Kapinous E. V. Yaroslavtseva I. S. Spichenkova A. M. Shubina O. V. Borgul Ju. A. Ragulin M. V. Taibova Photodynamic therapy for metastatic breast cancer Biomedical Photonics рак молочной железы фотолон фотодинамическая терапия внутрикожные метастазы |
title | Photodynamic therapy for metastatic breast cancer |
title_full | Photodynamic therapy for metastatic breast cancer |
title_fullStr | Photodynamic therapy for metastatic breast cancer |
title_full_unstemmed | Photodynamic therapy for metastatic breast cancer |
title_short | Photodynamic therapy for metastatic breast cancer |
title_sort | photodynamic therapy for metastatic breast cancer |
topic | рак молочной железы фотолон фотодинамическая терапия внутрикожные метастазы |
url | http://www.pdt-journal.com:80/jour/article/view/33 |
work_keys_str_mv | AT evhoranskaya photodynamictherapyformetastaticbreastcancer AT makaplan photodynamictherapyformetastaticbreastcancer AT vnkapinous photodynamictherapyformetastaticbreastcancer AT evyaroslavtseva photodynamictherapyformetastaticbreastcancer AT isspichenkova photodynamictherapyformetastaticbreastcancer AT amshubina photodynamictherapyformetastaticbreastcancer AT ovborgul photodynamictherapyformetastaticbreastcancer AT juaragulin photodynamictherapyformetastaticbreastcancer AT mvtaibova photodynamictherapyformetastaticbreastcancer |